electroCore to Participate at LD Micro Main Event VXII
Rhea-AI Summary
electroCore, a bioelectronic medicine and wellness company, has announced its participation in the LD Micro Main Event XVII on October 29, 2024, at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Dan Goldberger, CEO, will represent the company and be available for one-on-one meetings throughout the day.
The presentation is scheduled for 4:30 p.m. PT and will be accessible via a live audio webcast. Interested attendees can register for the conference or contact investors@electrocore.com to arrange meetings with management. The webcast link for the presentation is https://me24.sequireevents.com/
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ECOR declined 0.08%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Rockaway, New Jersey--(Newsfile Corp. - October 14, 2024) - electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the LD Micro Main Event XVII on Tuesday, October 29 at 4:30 p.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Dan Goldberger, CEO will be representing the company and will be available for one-on-one meetings throughout the day on October 29.
DATE: Tuesday, October 29, 2024
TIME: 4:30 p.m. PT
WEBCAST: https://me24.sequireevents.com/
A live audio webcast and archive of the presentation will be available using the above dedicated link. Attendees interested in meeting with management should register for the conference or email investors@electrocore.com.
About LD Micro
LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. Through the LD Micro Index and annual investor conferences, LD has served as an invaluable asset to all those interested in discovering the next generation of great companies. For more information of LD Micro, visit www.ldmicro.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation ("nVNS") technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/226272
FAQ
When and where is electroCore (ECOR) participating in the LD Micro Main Event XVII?
Who will be representing electroCore (ECOR) at the LD Micro Main Event XVII?
How can investors access electroCore's (ECOR) presentation at the LD Micro Main Event XVII?
Can investors schedule one-on-one meetings with electroCore (ECOR) management at the event?
